Tower Research Capital (TRC)’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-660
| Closed | – | – | 6779 |
|
|
2022
Q4 | $0 | Sell |
660
-10,029
| -94% | -$6.59K | ﹤0.01% | 6775 |
|
|
2022
Q3 | $13K | Sell |
10,689
-8,239
| -44% | -$12.8K | ﹤0.01% | 4314 |
|
|
2022
Q2 | $35K | Sell |
18,928
-97,743
| -84% | -$144K | ﹤0.01% | 3235 |
|
|
2022
Q1 | $236K | Buy |
116,671
+66,419
| +132% | +$130K | ﹤0.01% | 1614 |
|
|
2021
Q4 | $136K | Sell |
50,252
-8,327
| -14% | -$30.8K | ﹤0.01% | 2037 |
|
|
2021
Q3 | $262K | Buy |
58,579
+42,653
| +268% | +$205K | 0.01% | 1561 |
|
|
2021
Q2 | $92K | Buy |
15,926
+10,840
| +213% | +$63.5K | ﹤0.01% | 2501 |
|
|
2021
Q1 | $36K | Sell |
5,086
-4,436
| -47% | -$29.7K | ﹤0.01% | 3409 |
|
|
2020
Q4 | $46K | Sell |
9,522
-99,219
| -91% | -$502K | ﹤0.01% | 3202 |
|
|
2020
Q3 | $634K | Buy |
108,741
+60,152
| +124% | +$360K | 0.01% | 1420 |
|
|
2020
Q2 | $328K | Buy |
+48,589
| New | +$368K | 0.01% | 1368 |
|
|
2020
Q1 | – | Sell |
-222
| Closed | -$2K | – | 4210 |
|
|
2019
Q4 | $2K | Sell |
222
-299
| -57% | -$2.17K | ﹤0.01% | 3155 |
|
|
2019
Q3 | $2K | Buy |
521
+384
| +280% | +$3.11K | ﹤0.01% | 3775 |
|
|
2019
Q2 | $2K | Sell |
137
-480
| -78% | -$8.67K | ﹤0.01% | 3353 |
|
|
2019
Q1 | $15K | Buy |
617
+517
| +517% | +$13K | ﹤0.01% | 2457 |
|
|
2018
Q4 | $2K | Buy |
+100
| New | +$2.04K | ﹤0.01% | 3475 |
|
|
2018
Q2 | – | Sell |
-48
| Closed | -$3K | – | 4224 |
|
|
2018
Q1 | $3K | Sell |
48
-583
| -92% | -$34K | ﹤0.01% | 2895 |
|
|
2017
Q4 | $43K | Sell |
631
-2,372
| -79% | -$166K | 0.01% | 1448 |
|
|
2017
Q3 | $248K | Buy |
+3,003
| New | +$238K | 0.02% | 609 |
|
|
2017
Q2 | – | Sell |
-93
| Closed | -$6K | – | 3662 |
|
|
2017
Q1 | $6K | Sell |
93
-4,400
| -98% | -$267K | ﹤0.01% | 2137 |
|
|
2016
Q4 | $200K | Buy |
+4,493
| New | +$158K | 0.02% | 629 |
|
|
2016
Q3 | – | Sell |
-7,105
| Closed | -$98K | – | 4714 |
|
|
2016
Q2 | $98K | Buy |
7,105
+5,813
| +450% | +$85K | 0.01% | 1118 |
|
|
2016
Q1 | $25K | Sell |
1,292
-417
| -24% | -$8.83K | ﹤0.01% | 1204 |
|
|
2015
Q4 | $60K | Buy |
+1,709
| New | +$110K | 0.01% | 475 |
|
|
2015
Q3 | – | Sell |
-368
| Closed | -$32K | – | 5013 |
|
|
2015
Q2 | $32K | Sell |
368
-740
| -67% | -$63.3K | ﹤0.01% | 1728 |
|
|
2015
Q1 | $82K | Buy |
1,108
+1,071
| +2,895% | +$75.6K | 0.01% | 1057 |
|
|
2014
Q4 | $2K | Sell |
37
-59
| -61% | -$3.1K | ﹤0.01% | 3425 |
|
|
2014
Q3 | $4K | Sell |
96
-180
| -65% | -$7.52K | ﹤0.01% | 3489 |
|
|
2014
Q2 | $11K | Sell |
276
-1,030
| -79% | -$53K | ﹤0.01% | 2301 |
|
|
2014
Q1 | $90K | Buy |
1,306
+650
| +99% | +$47.7K | 0.01% | 766 |
|
|
2013
Q4 | $40K | Sell |
656
-529
| -45% | -$28.8K | 0.01% | 1589 |
|
|
2013
Q3 | $72K | Buy |
1,185
+35
| +3% | +$2.48K | 0.01% | 1598 |
|
|
2013
Q2 | $77K | Buy |
+1,150
| New | +$51.7K | 0.01% | 644 |
|
Other funds holding CLVS
Tower Research Capital (TRC)'s CLVS Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of Clovis Oncology, Inc. (CLVS) in Q1 2023, closing a stake of 660 shares.
Tower Research Capital (TRC) first reported a position in CLVS in Q2 2013 and held it in 33 quarters. The position peaked at $634K in Q3 2020. 2 funds tracked by Wall St. Rank hold CLVS as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining Clovis Oncology, Inc. position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 660 Clovis Oncology, Inc. shares in Q1 2023.
- Tower Research Capital (TRC) first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 33 quarters.
- Tower Research Capital (TRC)'s Clovis Oncology, Inc. position peaked at $634K in Q3 2020.
- 2 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.